Javascript must be enabled to continue!
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
View through CrossRef
<p>Supplementary figures (1-12) Supplemental Fig. 1. Normalized levels of monoubiquitinated mutant p53 are shown for indicated cell lines analyzed in Fig. 1a. Supplemental Fig. 2. Longer single exposure of p53 blot in Fig. 2a is displayed to demonstrate the relative abundance of monoubiquitinated to native species. Supplemental Fig 3. (a) WI38 cells were transfected with p53-273H and MDM2 for 40- 48 hours later, and plates were treated with 2 μM Dox for 2 hours in the presence or absence of 2 mM caffeine. Caffeine-treated samples were pre-treated with 2 mM caffeine for 20 min prior to addition of Dox. Supplemental Fig. 4. Normalized levels of monoubiquitinated or native mutant p53 from p53-273H-expressing H1299 cells analyzed in Fig. 2c are shown. Supplemental Fig. 5. Normalized levels of monoubiquitinated and native mutant p53, as well as MDM2, are shown for ABC1-shGFP and ABC1-shMDM2 cells analyzed in Fig. 3a. Supplemental Fig. 6. Normalized levels of monoubiquitinated or native mutant p53 are shown from p53-273H-expressing H1299 cells co expressing wt vs. RING mutated MDM2 analyzed in Fig. 3b. Supplemental Fig. 7. Normalized levels of monoubiquitinated or native mutant p53, as well as p53 S15-p, are shown for p53-273H-expressing H1299 cells analyzed in Fig. 4a. Supplemental Fig. 8. Normalized levels of polyubiquitinated p53 mutant p53 are shown for H1048 cells analyzed in Fig. 5b. Supplemental Fig. 9. Normalized levels of polyubiquitinated p53 are shown in p53- 273H-expressing H1299 cells analyzed in Fig. 5c after mock, Dox or Dox+caffeine treatment. Supplemental Fig. 10. (a) H1048 cells were mock-treated or treated with caffeine and/or MG132 for 7 hours and fixed and analyzed by flow cytometry for p53. (b) ABC1 shGFP or shMDM2-expressing cells were treated with or without caffeine, and stained for p53 level by flow cytometry. Supplemental Fig 11. (a) H1975, (b) MDA MB 231, (c) WI38, or d) U2OS cells were mock-treated or treated with caffeine for 7 hours and fixed and analyzed by flow cytometry for p53. Supplemental Fig. 12. The level of total ATM in siATM or control siRNA transfected H1048 cells is shown. Actin was immunoblotted as a loading control.</p>
American Association for Cancer Research (AACR)
Title: Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Description:
<p>Supplementary figures (1-12) Supplemental Fig.
1.
Normalized levels of monoubiquitinated mutant p53 are shown for indicated cell lines analyzed in Fig.
1a.
Supplemental Fig.
2.
Longer single exposure of p53 blot in Fig.
2a is displayed to demonstrate the relative abundance of monoubiquitinated to native species.
Supplemental Fig 3.
(a) WI38 cells were transfected with p53-273H and MDM2 for 40- 48 hours later, and plates were treated with 2 μM Dox for 2 hours in the presence or absence of 2 mM caffeine.
Caffeine-treated samples were pre-treated with 2 mM caffeine for 20 min prior to addition of Dox.
Supplemental Fig.
4.
Normalized levels of monoubiquitinated or native mutant p53 from p53-273H-expressing H1299 cells analyzed in Fig.
2c are shown.
Supplemental Fig.
5.
Normalized levels of monoubiquitinated and native mutant p53, as well as MDM2, are shown for ABC1-shGFP and ABC1-shMDM2 cells analyzed in Fig.
3a.
Supplemental Fig.
6.
Normalized levels of monoubiquitinated or native mutant p53 are shown from p53-273H-expressing H1299 cells co expressing wt vs.
RING mutated MDM2 analyzed in Fig.
3b.
Supplemental Fig.
7.
Normalized levels of monoubiquitinated or native mutant p53, as well as p53 S15-p, are shown for p53-273H-expressing H1299 cells analyzed in Fig.
4a.
Supplemental Fig.
8.
Normalized levels of polyubiquitinated p53 mutant p53 are shown for H1048 cells analyzed in Fig.
5b.
Supplemental Fig.
9.
Normalized levels of polyubiquitinated p53 are shown in p53- 273H-expressing H1299 cells analyzed in Fig.
5c after mock, Dox or Dox+caffeine treatment.
Supplemental Fig.
10.
(a) H1048 cells were mock-treated or treated with caffeine and/or MG132 for 7 hours and fixed and analyzed by flow cytometry for p53.
(b) ABC1 shGFP or shMDM2-expressing cells were treated with or without caffeine, and stained for p53 level by flow cytometry.
Supplemental Fig 11.
(a) H1975, (b) MDA MB 231, (c) WI38, or d) U2OS cells were mock-treated or treated with caffeine for 7 hours and fixed and analyzed by flow cytometry for p53.
Supplemental Fig.
12.
The level of total ATM in siATM or control siRNA transfected H1048 cells is shown.
Actin was immunoblotted as a loading control.
</p>.
Related Results
Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Abstract
Many mutant p53 proteins exhibit an abnormally long half-life and overall increased abundance compared with wild-type p53 in tumors, contributing to muta...
Data from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Data from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
<div>Abstract<p>Many mutant p53 proteins exhibit an abnormally long half-life and overall increased abundance compared with wild-type p53 in tumors, contributing to mut...
Data from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Data from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
<div>Abstract<p>Many mutant p53 proteins exhibit an abnormally long half-life and overall increased abundance compared with wild-type p53 in tumors, contributing to mut...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
Supp. Figs. 1-12 from Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination
<p>Supplementary figures (1-12) Supplemental Fig. 1. Normalized levels of monoubiquitinated mutant p53 are shown for indicated cell lines analyzed in Fig. 1a. Supplemental Fi...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
DdcA antagonizes a bacterial DNA damage checkpoint
DdcA antagonizes a bacterial DNA damage checkpoint
AbstractBacteria coordinate DNA replication and cell division, ensuring that a complete set of genetic material is passed onto the next generation. When bacteria encounter DNA dama...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...

